Previously Published on NewsWire.com — Beta Bionics, Inc. — a medical technology company focused on diabetes — announces FDA 510(k) clearance and the commercial launch of the iLet Bionic Pancreas. The iLet is the first and only automated insulin-delivery system that does not require carb counting and fully automates 100% of all user insulin doses – which means…
Previously Published on diaTribe.org – Impressive results from a trial for an up-and-coming artificial pancreas showed that users spent an average of 2.6 more hours in range each day compared to non-users – all without counting carbs. Here’s what trial participants are saying about the new system, The iLet Bionic Pancreas. What is the iLet Bionic Pancreas?…
Previously Published on medwireNews – The iLet bionic pancreas closed-loop insulin delivery system provides good glucose control without the need for the user to count carbohydrates, show findings from the pivotal trial. Bionic pancreas removes math from diabetes. Instead of counting carbohydrates, users of the Beta Bionics iLet insulin-only bionic pancreas just make meal announcements with the modifier of…
Today Beta Bionics was granted FDA breakthrough device designation for the iLet bionic pancreas system. The designation was granted in all configurations of the iLet (insulin-only, glucagon-only and bihormonal). The meaning of FDA breakthrough device designation is to provide patients and health care providers with timely access to medical devices by speeding up their development, assessment, and review….
Beta Bionics announced a pivotal bihormonal iLet home trial using both dasiglucagon and insulin in the aforementioned bionic pancreas. The iLet (dual-hormone pump system) designed to autonomously deliver insulin and dasiglucagon. The bionic pancreas offers people with type 1 diabetes, safer and easier blood sugar control. Therefore, better long-term management and outcomes are possible as well. What is…
Bionic Pancreas Critical Hurdle! Beta Bionics recently won $12 million in supplemental funding from the National Institutes of Health (NIH) to conduct a major multicenter, national clinical trials for the iLet™ (bionic pancreas). Developed by Edward Damiano (Beta Bionics) and Firas El-Khatib. They hope to have the device approved for market in about a year….
The Bionic Pancreas called “iLet” by Beta Bionics. The only fully integrated, fully automated, bihormonal bionic pancreas. The device uses both, insulin to lower blood sugar and glucagon to raise blood sugar for optimal glycemic control, a bridge to a cure. As I write this, the pump device is not yet available to the public. A…
The Artificial Pancreas is a smart idea and does show promise in controlling blood sugars for type 1 diabetics who are currently using insulin pumps. The system uses a modified iPhone connected to a glucose monitor and pumps that deliver the insulin and glucagon. It mimics the natural release of daily insulin and eliminates injections….